Ronald Silver - 29 Aug 2023 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
Principal Accounting Officer
Signature
/s/ Brian Tessler, Attorney-in-Fact
Issuer symbol
IRWD
Transactions as of
29 Aug 2023
Net transactions value
$0
Form type
4
Filing time
31 Aug 2023, 16:05:07 UTC
Previous filing
16 Aug 2023
Next filing
14 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRWD Class A Common Stock Award $0 +8,000 +6% $0.000000 142,172 29 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock unit award, granted as a recognition award, vests as to 50% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.